SMS Pharmaceuticals Ltd SMSPHARMA-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 2:59 PM IST
86.90quote price arrow down-0.20 (-0.23%)
Volume
24,169
52 week range
68.40 - 194.60
Loading...
  • Open87.95
  • Day High89.00
  • Day Low86.00
  • Prev Close87.10
  • 52 Week High194.60
  • 52 Week High Date08/09/21
  • 52 Week Low68.40
  • 52 Week Low Date06/09/22

Key Stats

  • Market Cap92.83M
  • Shares Out84.65M
  • 10 Day Average Volume41,043.5
  • Dividend0.30
  • Dividend Yield0.35%
  • Beta-
  • YTD % Change-32.16

KEY STATS

  • Open87.95
  • Day High89.00
  • Day Low86.00
  • Prev Close87.10
  • 52 Week High194.60
  • 52 Week High Date08/09/21
  • 52 Week Low68.40
  • 52 Week Low Date06/09/22
  • Market Cap92.83M
  • Shares Out84.65M
  • 10 Day Average Volume41,043.5
  • Dividend0.30
  • Dividend Yield0.35%
  • Beta-
  • YTD % Change-32.16

RATIOS/PROFITABILITY

  • EPS (TTM)7.30
  • P/E (TTM)11.90
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/22/2021
  • Div Amount0.30
  • Split Date-
  • Split Factor-

Latest On SMS Pharmaceuticals Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
SMS Pharmaceuticals Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in the business of manufacturing active pharma ingredients (API) and their intermediates. The Company's API products include Ranitidine HCL (Form-2) USP / Ph.Eur, Famotidine USP / Ph. Eur / JP, Pantoprazole Sodium Sesquihydrate US/Ph. Eur, Itraconazole USP / Ph.Eur / JP, Lanoconazole USP / JP, Sumatriptan Succinate USP / Ph.Eur/ BP, Sumatriptan Base USP / Ph.Eur/ BP...
Ramesh Potluri
Executive Chairman of the Board, Managing Director
N. Rajendra Prasad
Chief Financial Officer
Address
Plot No.19-III,OP BHARATIYA VIDYA BHAVAN
PUBLIC ROAD NO 71, JUBILEE HILLS
Hyderabad
500096
India